Trichloroacetic acid: Updated estimates of its bioavailability and its contribution to trichloroethylene-induced mouse hepatomegaly

Toxicology

Volumn 285, Issue 3, 2011, Pages 114-125

  Chiu, Weihsueh A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Bayesian; Hepatomegaly; Metabolism; Physiologically based pharmacokinetic (PBPK) model; Trichloroethylene; Trichoroacetic acid

Indexed keywords

DRINKING WATER; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; CALCULATION; DOSE RESPONSE; HEPATOMEGALY; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; HEPATOMEGALY; LIVER; MALE; MICE; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

MUS;

EID: 79957869219     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.04.009     Document Type: Article

References (45)

1. Abbas R., Fisher J.W. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 1997, 147:15-30.
2. Abbas R., Seckel C.S., MacMahon K.L., Fisher J.W. Determination of kinetic rate constants for chloral hydrate, trichloroethanol, trichloroacetic acid, and dichloroacetic acid-a physiologically based modeling approach. Toxicologist 1997, 36:32-33.
3. Bois F.Y. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 2000, 108(Suppl. 2):275-282.
4. Bois F.Y. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 2000, 108(Suppl. 2):307-316.
5. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., Beliles R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 1997, 13:407-484.
6. Buben J.A., O'Flaherty E.J. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. Toxicol. Appl. Pharmacol. 1985, 78(1):105-122.
7. Chiu W.A., Okino M.S., Evans M.V. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach. Toxicol. Appl. Pharmacol. 2009, 241(1):36-60.
8. DeAngelo A.B., Daniel F.B., McMillan I., Wernsing P., Savage R.E. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol. Appl. Pharmacol. 1989, 101:285-298.
9. DeAngelo A.B., George M.H., House D.E. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J. Toxicol. Environ. Health 1999, 58:485-507.
10. DeAngelo A.B., Daniel F.B., Wong D.M., George M.H. The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J. Toxicol. Environ. Health A 2008, 71:1056-1068.
11. Evans M.V., Chiu W.A., Okino M.S., Caldwell J.C. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly. Toxicol. Appl. Pharmacol. 2009, 236(3):329-340.
12. Fisher J.W., Mahle D., Abbas R. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 1998, 152:339-359.
13. Gelman A., Bois F., Jiang J. Physiological pharmacokinetic analysis using population modeling and infromatibe prior distributions. J. Am. Stat. Assoc. 1996, 91:1400-1412.
14. Gelman A., Carlin J.B., Stern H.S., Rubin D.B. Bayesian Data Analysis 2004, Chapman & Hall/CRC, New York.
15. Goel S.K., Rao G.S., Pandya K.P., Shanker R. Trichloroethylene toxicity in mice: a biochemical, hematological and pathological assessment. Indian J. Exp. Biol. 1992, 30:402-406.
16. Green T., Prout M.S. Species differences in response to trichloroethylene. II. Biotransformation in rats and mice. Toxicol. Appl. Pharmacol. 1985, 79:401-411.
17. Green T. The Concentrations of Trichloroacetic Acid in Blood Following Administration of Trichloroacetic Acid in Drinking Water 2003, Central Toxicology Laboratory, Alderley Park Macclesfield, Cheshire, UK.
18. Green T. Perchloroethylene Induced Mouse Liver Tumours: Mode of Action Studies 2003, Central Toxicology Laboratory, Alderley Park Macclesfield, Cheshire, UK, Document number CTL/024741/RES/REPT-001, August 6, 2003.
19. Hack C.E., Chiu W.A., Jay Zhao Q., Clewell H.J. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. Regul. Toxicol. Pharmacol. 2006, 46:63-83.
20. Hejtmancik M.R., Trela B.A., Kurtz P.J., Persing R.L., Ryan M.J., Yarrington J.T., Chhabra R.S. Comparative gavage subchronic toxicity studies of o-chloroaniline and m-chloroaniline in F344 rats and B6C3F1 mice. Toxicol. Sci. 2002, 69:234-243.
21. ICRP Publication 89 Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiolog
22. Kato-Weinstein J., Stauber A.J., Orner G.A., Thrall B.D., Bull R.J. Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3 F1 mice. J. Appl. Toxicol. 2001, 21:81-89.
23. Ketcha M.M., Stevens D.K., Warren D.A., Bishop C.T., Brashear W.T. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol. 1996, 20(4):236-241.
24. Kim S., Collins L.B., Boysen G., Swenberg J.A., Gold A., Ball L.M., Bradford B.U., Rusyn I. Liquid chromatography electrospray ionization tandem mass spectrometry analysis method for simultaneous detection of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine. Toxicology 2009, 262(3):230-238.
25. Kjellstrand P., Holmquist B., Alm P., Kanje M., Romare S., Jonsson I., Mannson L., Bjerkemo M. Trichloroethylene: further studies of the effects on body and organ weights and plasma butyrylcholinesterase activity in mice. Acta Pharmacol. Toxicol. 1983, 53:375-384.
26. Larson J.L., Bull R.J. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 1992, 115:268-277.
27. Lin J.H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 1995, 23:1008-1021.
28. Lumpkin M.H., Bruckner J.V., Campbell J.L., Dallas C.E., White C.A., Fisher J.W. Plasma binding of trichloroacetic acid in mice, rats, and humans under cancer bioassay and environmental exposure conditions. Drug Metab. Dispos. 2003, 31:1203-1207.
29. Mahle D.A., Godfrey R.J., Buttler G.W., Narayanan L., Taylor A., Fisher J.W. Pharmacokinetics and Metabolism of Dichloroacetic Acid and Trichloroacetic Acid Administered in Drinking Water in Rats and Mice 2001, United States Air Force Research Laboratory, Wright Patterson Air Force Base, OH, AFRL-HE-WP-TR-2001-0059.
30. Marino D.J., Clewell H.J., Gentry P.R., Covington T.R., Hack C.E., David R.M., Morgott D.A. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. Regul. Toxicol. Pharmacol. 2006, 45:44-54.
31. Merdink J.L., Gonzalez-Leon A., Bull R.J., Schultz I.R. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. Toxicol. Sci. 1998, 45(1):33-41.
32. Merrick B.A., Robinson M., Condi L.W. Differing hepatotoxicity and lethality after subacute trichloroethylene exposure in aqueous or corn oil gavage vehicles in B6C3F1 mice. J. Appl. Toxicol. 1989, 9:15-21.
33. National Research Council (NRC) Key Scientific Issues in the Health Risk Assessment of Trichloroethylene 2006, National Academy Press, Washington.
34. National Research Council (NRC) Review of the Environmental Protection Agency's Draft IRIS Assessment of Tetrachloroethylene 2010, National Academy Press, Washington.
35. Parrish J.M., Austin E.W., Stevens D.K., Kinder D.H., Bull R.J. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 1996, 110:103-111.
36. Sarangapani R., Gentry P.R., Covington T.R., Teeguarden J.G., Clewell H.J. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal. Toxicol. 2003, 15:987-1016.
37. Schultz I.R., Merdink J.L., Gonzalez-Leon A., Bull R.J. Comparative toxicokinetics of chlorinated and brominated haloacetates in F344 rats. Toxicol. Appl. Pharmacol. 1999, 158:103-114.
38. Spiegelhalter D.J., Best N.G., Carlin B.P., van der Linde A. Bayesian measures of model complexity and fit (with discussion). J. R. Stat. Soc. B (Statistical Method.) 2002, 64(October (4)):583-639.
39. Stenner R.D., Merdink J.L., Stevens D.K., Springer D.L., Bull R.J. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene. Drug Metab. Dispos. 1997, 25(5):529-535.
40. Stenner R.D., Merdink J.L., Fisher J.W., Bull R.J. Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Anal. 1998, 18(3):261-269.
41. Sweeney L.M., Kirman C.R., Gargas M.L., Dugard P.H. Contribution of trichloroacetic acid to liver tumors observed in perchloroethylene (perc)-exposed mice. Toxicology 2009, 260(1-3):77-83.
42. Templin M.V., Parker J.C., Bull R.J. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 1993, 123:1-8.
43. Templin M.V., Stevens D.K., Stenner R.D., Bonate P.L., Tuman D., Bull R.J. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J. Toxicol. Environ. Health 1995, 44:435-447.
44. Yuan J. Effects of drinking pattern on the peak/trough blood concentrations in drinking water studies. Food Chem. Toxicol. 1995, 33(July (7)):565-571.
45. Yu K.O., Barton H.A., Mahle D.A., Frazier J.M. In vivo kinetics of trichloroacetate in male Fischer 344 rats. Toxicol. Sci. 2000, 54:302-311.